CALT
$17.85
Calliditas Therapeutics Ab ADR
($1.36)
(7.08%)
CALT
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.82)
Revenue:  $0.59 Mil
Thursday
Feb 17
1:10 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, November 18, 2021

What do you expect when CALT reports earnings?
Beat
Meet
Miss

Where is CALT's stock price going from here?
Up
Flat
Down
Stock chart of CALT
Analysts
Summary of analysts' recommendations for CALT
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Calliditas Therapeutics AB is a specialty pharmaceutical company. It is focused on developing pharmaceutical products for patients with a significant unmet medical need. The compnay's lead candidate consist Nefecon. Calliditas Therapeutics AB is based in Stockholm, Sweden.